Introdução: O Diabetes mellitus (DM) está associado a complicações crônicas micro e macrovasculares. A medida da hemoglobina glicada (HbA1c) avalia o grau do controle glicêmico em pacientes diabéticos e seus níveis são capazes de prognosticar o risco de desenvolvimento dessas complicações. Entre as origens das complicações causadas pela hiperglicemia, há a hipótese dos produtos finais de glicação avançada (AGEs) e do estresse oxidativo. A reação de glicação não enzimática das proteínas também está relacionada com as complicações diabéticas e é responsável pela formação da HbA1c. Entretanto, tem sido demonstrado um aumento dessa glicação em pacientes não diabéticos. Um dos prováveis mecanismos para esse aumento é a peroxidação lipídica, com conseqüente aumento nos níveis de malondialdeído (MDA) que modifica a apolipoproteína B (APO B) do colesterol de baixa densidade (LDL). A modificação oxidativa do LDL confere propriedades específicas pró-aterogênicas. A presença do LDL oxidado e o aumento da tendência do LDL à peroxidação lipídica, podem contribuir para o aumento dos níveis de HbA1c. Objetivo: Verificar a associação entre os níveis de HbA1c com o Colesterol LDL e LDL oxidado em Indivíduos não-diabéticos. Métodos: Foi realizado um estudo transversal observacional, no qual um total de 196 indivíduos, classificados como não-diabéticos, foram analisados e divididos em três grupos, conforme os valores de HbA1c e glicemia de jejum (GJ): Grupo 1 (n =64) - HbA1c <5,7% e GJ <100 mg/dL; Grupo 2 (n =69) - HbA1c ≥5,7 e ≤6,4% e GJ <100 mg/dL; Grupo 3 (n =63) - HbA1c ≥5,7 e ≤6,4% e GJ ≥100 e <126mg/dL. Amostras de sangue total e soro foram coletadas. O LDL oxidado foi medido por método imunoensaio enzimático (Mercodia ®), ApoB dosada por imunoturbidimentria, a relação Colesterol LDL(oxi)/Colesterol-HDL foi estimada, além das outras dosagens bioquímicas do perfil lipídico. Esses testes foram comparados e analisados entre os três diferentes grupos. Resultados: Houve diferença significativa nos níveis de LDL(oxi) (p< 0,001), Apo B (p= 0,026) e razão LDL(oxi)/HDL (p< 0,001) entre os três grupos. Os valores de HbA1c apresentaram correlação positiva com os valores de LDL (oxi) (r =0,431; p <0,001), LDL (r =0,148; p =0,039), Col Não-HDL (r =0,192; p =0,007) e Apo B (r =0,171; p <0,001). Estas associações positivas permaneceram significativas, mesmo após ajuste, por análise de regressão linear múltipla para as variáveis álcool, medicamentos, índice de massa corporal (IMC) e idade. Também apresentaram correlações positivas com os valores de HbA1c: razão LDL (oxi)/HDL (r =0,422; p <0,001), CT (r =0,142; p =0,048), triglicerídios (r =0,155; p =0,030) e IMC (r =0,263; p <0,001). Conclusão: Nosso estudo demonstrou associação dos níveis de HbA1c com as partículas lipídicas aterogênicas LDL, Apo B, colesterol não HDL e LDL (oxi). Os níveis de LDL, principalmente LDL (oxi), estão significativamente associados com os níveis de HbA1c e glicose, mesmo em indivíduos não-diabéticos. Os indivíduos classificados com alto risco de desenvolver DM ou DCV apresentam valores mais elevados de partículas de LDL oxidadas. Nossos dados sugerem que a presença de LDL (oxi) está relacionada com a glicação e ao aumento dos níveis sanguíneos de HbA1c em indivíduos não diabéticos. / Background: Diabetes mellitus (DM) is associated with chronic microvascular and macrovascular complications. The measurement of glycated hemoglobin (HbA1c) assesses the degree of glycemic control in diabetics patients and their levels are able to predict the risk of developing these complications. The formation of advanced glycation and products (AGEs) and oxidative stress are some of the hypothesis described to explain the diabetic complications. The reaction of nonenzymatic glycation of proteins is also related to these complications and is responsible for the formation of HbA1c. However, it has been shown an increase in glycation in nondiabetic patients, which is maybe due to lipid peroxidation, consequently, the levels of malondialdehyde (MDA) increase and there is modifications in the apolipoprotein B (apoB) of low-density cholesterol (LDL). The oxidative modification of LDL confers specific proatherogenic properties. The presence of oxidized LDL and an increased tendency to LDL peroxidation contribute to increased levels of HbA1c in diabetic patients. Objective: To investigate the association between HbA1c levels and the levels of LDL cholesterol and oxidized LDL in subjects without diabetes. Methods: We conducted an observational cross-sectional study in which a total of 196 individuals, classified as non-diabetics, were analyzed and divided into three groups according to the values of HbA1c and fasting plasma glucose (FPG): Group 1 (n = 64) - HbA1c <5.7% and FPG <100 mg / dL, Group 2 (n = 69) - HbA1c ≥ 5.7 and ≤ 6.4% and FPG <100 mg / dL, Group 3 (n = 63) - HbA1c ≥ 5.7 and ≤ 6.4% and FPG ≥ 100 and <126mg/dL. Samples of whole blood and serum were collected. Oxidized LDL was measured by enzyme immunoassay method (Mercodia ®), ApoB was measured by imunoturbidimentria and the ratio LDL cholesterol (oxi) / HDL-cholesterol was estimated. Other biochemical measurements of lipid profile were also carried out. Results: There were significant differences in LDL (oxi) (p <0.001), Apo B (p = 0.026), and ratio LDL (oxi) / HDL (p <0.001) between the three groups. HbA1c values showed positive association with LDL (oxi) (r = 0.431, p <0.001), LDL (r = 0.148, p = 0.039), non-HDL Col (r = 0.192, p = 0.007) and Apo B (r = 0.171, p <0.001). These positive associations remained significant even after adjustment for multiple linear regression analysis for variables such as alcohol, drugs, BMI and age. The ratio LDL (oxi) / HDL (r = 0.422, p <0.001), CT (r = 0.142, p = 0.048), triglycerides (r = 0.155, p = 0.030) and BMI (r = 0.263, p <0.001) also showed positive correlations with HbA1c values. Conclusions: Our study demonstrated that there is association between HbA1c levels and the atherogenic lipid particles LDL, Apo B, non-HDL cholesterol and LDL (oxi). LDL levels, especially LDL (oxi), are significantly associated with HbA1c and glucose levels, even in non-diabetics. Individuals classified with high risk of developing diabetes or CVD have higher levels of oxidized LDL particles. Our data suggest that the presence of LDL (oxi) is related to glycation and increased blood levels of HbA1c in nondiabetic individuals.

Submitted by Angela Maria de Oliveira (amolivei@uepg.br) on 2017-11-14T16:10:19Z No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Paula Souza de Freitas.pdf: 1924040 bytes, checksum: fefa81c1aecd3b9f1256ca52a260ba88 (MD5) / Made available in DSpace on 2017-11-14T16:10:19Z (GMT). No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Paula Souza de Freitas.pdf: 1924040 bytes, checksum: fefa81c1aecd3b9f1256ca52a260ba88 (MD5) Previous issue date: 2016-02-26 / Introdução: O Diabetes mellitus é considerado uma epidemia mundial. Atualmente 415 milhões de pessoas tem diabetes no mundo e no Brasil este número é superior a 14 milhões. Estimado como um dos principais problemas de saúde pública no país, conhecer a população quem convive com o diabetes é de grande importância para que se possam introduzir orientações que contribuam para um adequado controle glicêmico melhorando assim a sua qualidade de vida. Objetivos: Avaliar a qualidade de vida dos pacientes com diabetes tipo 1 em tratamento com insulinas convencionais NPH e Regular. Metodologia: Trata-se de estudo observacional, retrospectivo e transversal. Foram entrevistados 44 pacientes com DM1, maiores de 18 anos, que faziam uso de insulina convencional. Os dados sociodemográficos, clínicos e do tratamento foram coletados a partir de três fontes, (1) prontuários do Centro Municipal de Especialidades, (2) prontuários do Hospital Santa Casa de Misericórdia e (3) ficha individual por meio da entrevista. Avaliou-se a qualidade de vida por meio do instrumento DQOL-Brasil. Resultados: Dos 44 pacientes entrevistados, 40,9% eram mulheres e 59,1% homens; 56,9% tinham idade entre 26 e 46 anos; 81,7% residiam em Ponta Grossa – PR; 43,2% solteiros, 36,3% casados, 13,6% moram juntos e 6,9 divorciados. Considerando a formação escolar 36,3% tinham o ensino médio completo; a renda média foi de R$1826,72 reais; 40,9% conviviam com o diabetes há 16 e 25 anos. Entre eles, 61,3% apresentavam alguma complicação, como retinopatia, pé diabético, hipercolesterolemia, problemas vasculares e nefropatia. A hemoglobina glicada de até 7% foi observada em apenas 6,9% do total dos entrevistados. A média da qualidade de vida observada nos pacientes com insulinas convencionais foi de 3,0. Conclusão: O mau controle glicêmico pode afetar a percepção de qualidade de vida de pacientes com diabetes mellitus tipo 1. Devido à inexistência de um sistema que contemplem tanto dados sociodemográficos quanto clínicos, se faz cada vez mais necessário, conhecer essa população na busca de estratégias para melhorar a saúde dos pacientes e melhorar a sua qualidade de vida. / Introduction: Diabetes mellitus is considered and epidemic worldwide. Currently 415 million people have diabetes worldwide and in Brazil this number is over 14 million. Estimated as a major public health problems in the country, meet the people who live with diabetes is of great importance so that they can introduce guidelines that contribute to an adequate glycemic control thus improving their quality of life. Aims: To assess the quality of life of patients with type 1 diabetes treated with conventional insulin NPH and Regular. Methodology: This is an observational, retrospective and cross-sectional study. Interviewed 44 patients with DM1, older than18 years, who used conventional insulin. The socio-demographic, clinical and treatment data were collected from three sources, (1) records of the Municipal Center of specialties, (2) Hospital records Santa Casa de Misericordia and (3) individual records through the interview. We evaluated the quality of life through DQOL-Brazil instrument. Results: Of the 44 patients interviewed, 40.9% were women and 59.1% men; 56.9% were aged between 26 and 46 years; 81.7% lived in Ponta Grossa - PR; 43.2% single, 36.3% married, 36.3% were married, 13.6% and 6.9 cohabiting divorced. Considering school education 36.3% had completed high school; the average income was R $ 1,826.72 reais; 40.9% lived with diabetes for 16 to 25 years. Among them, 61.3% had some complications, such as retinopathy, diabetic foot, hypercholesterolemia, vascular disease and nephropathy. The glycated hemoglobin up to 7% was observed in only 6.9% of total respondents. The average quality of life in the patients with conventional insulins was 3.0. Conclusion: The poor glycemic control can affect the perception of quality of life of patients with diabetes mellitus type 1. In the absence of a system that address both demographic as clinical data, it is increasingly necessary to meet this population in search strategies to improve the health of patients and improve their quality of life.

Reducing diabetes risk among Hispanic-American adults in the United States is a critical public health need and programs targeting young Hispanic-American adults with prediabetes can reduce the risk for developing diabetes. The purpose of this project was twofold: (a) to examine the literature related to diabetes prevention best practices among young adult Hispanic-Americans with prediabetes and (b) create an intervention program to promote these best practices to delay or reverse the trajectory toward diabetes. The inclusion criteria for the literature review were studies with at least a 12-month follow-up and reported outcomes related to changes in diet, increased exercise, and the effects of psychotherapy as modeled in the Diabetes Prevention Program (DPP). Studies that met these inclusion criteria for the period 2002 through January 2016 were evaluated and 11 studies supported the development of recommendations for future implementation. Pender's health promotion model provided useful theoretical support for the effectiveness of individual health behavior changes to reduce the risk of developing diabetes. Based on the literature review, proposed interventions included dietary interventions, behavior modifications, and both aerobic and resistance exercise training adapted for the young adult Hispanic-American population. The planned interventions will fill an evidence-to-practice gap in application of the DPP. The program when implemented will promote social change through lifestyle modifications among young adult Hispanic-Americans with prediabetes and is expected to improve dietary intake, weekly exercise, fasting glucose, and glucose tolerance and support weight loss, all of which can delay or stop progression to diabetes.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Segundo a American Diabetes Association, é importante a ênfase no controle glicêmico com o objetivo de prevenir complicações microvasculares em diabéticos, e a adoção de um plano alimentar saudável é fundamental no tratamento destes pacientes. O método de contagem de carboidratos é uma estratégia nutricional, é um método usado por indivíduos diabéticos, que associa o total de carboidratos ingerido nas refeições com a dose de insulina utilizada, com o objetivo de manter a glicemia dentro dos limites convenientes. O objetivo desse estudo foi avaliar se a intervenção nutricional, utilizando o método de contagem de carboidratos, influencia o controle glicêmico de pacientes com diabetes mellitus tipo 1 (DM1). Foram avaliados 157 DM1, 96 constituíram o grupo intervenção com dieta prescrita e com o uso do método de contagem de carboidratos e 61 pacientes DM1 constituíram o grupo controle com dieta prescrita e sem contagem de carboidratos. Os diabéticos foram monitorados por um período de seis meses. Na primeira visita foram submetidos a um questionário de caracterização dos indivíduos, avaliação antropométrica, bioquímica, clínica e dietética. Houve diferença significativa entre o registro alimentar preenchido durante 3 dias e a dieta prescrita, nos gramas de proteína consumidos por dia 50,39 + 29,27 e 22,01 + 3,05 (p= 0,02), como também no índice glicêmico (IG) do almoço 43,00 + 24,89 e 7,83 + 1,88 (p=0,02), e do jantar 50,09 + 35,09 e 7,56 + 2,57 (p=0,00). Em relação a avaliação antropométrica houve aumento não significativo em ambos os grupos, no Índice de Massa Corporal calculado e nos parâmetros antropométricos (circunferência abdominal, circunferência de quadril e relação cintura-quadril). Na avaliação dos parâmetros bioquímicos, observa-se diminuição significativa, somente no grupo intervenção, da hemoglobina glicada (A1C) de 9,8 + 2,26 para 9,1 + 2,16 (p= 0,023) após 6 meses. As correlações entre os dados antropométricos e a A1C, e entre os diferentes tipos de ácidos graxos da dieta proposta e parâmetros bioquímicos colesterol, triglicerídeos, HDLc e LDLc plasmáticos foram consideradas de baixa intensidade. Diante dos resultados concluiu-se que a intervenção por meio do método de contagem de carboidratos proporcionou uma melhora significativa no controle glicêmico dos pacientes estudados. / According to the American Diabetes Association, is important to focus on glycemic control in order to prevent microvascular complications in patients with type 1 diabetes, and the adoption of a plan healthy food is crucial in treating these patients. The method of carbohydrate counting is a nutritional strategy, it is a method used by diabetic individuals, which combines the total carbohydrate intake at meals with the dose of insulin used, with the goal of maintaining blood glucose within the limits appropriate. The aim of this study was to assess whether the nutrition intervention, using the method of carbohydrate couting, influences the glycemic control of patients with diabetes mellitus type 1 (DM1). We evaluated 157 DM1, 96 constituted the intervention group with diet and the use of the method of carbohydrate counting and 61 DM1 patients formed the control group with diet and without the method of carbohydrate counting. The patients were monitored for six months. In the first visit were submitted to a questionnaire, anthropometric, biochemical, clinical and dietary evaluations. Significant difference between the food record completed for 3 days and prescribed diet, in grams of protein consumed per day 50.39 + 29.27 and 22.01 + 3.05 (p = 0.02), on the glycemic index (GI) of lunch 43.00 + 24.89 and 7.83 + 1.88 (p = 0.02), and dinner 50.09 + 35.09 and 7.56 + 2.57 (p = 0.00). For anthropometric assessment increase was not significant in both groups, the body mass index and anthropometric parameters (waist circumference, hip circumference and the waist-hip ratio). In the assessment of biochemical parameters, there is a significant decrease, only in the intervention group, the glycated hemoglobin (A1C) from 9.8 + 2.26 to 9,1 + 2.16 (p = 0.023) after 6 months. The correlations between the anthropometric data and A1C, and between different types of fatty acids in the diet proposal and biochemical parameters cholesterol, triglycerides, HDLc and LDLc plasma were of low intensity. The results concluded that intervention by the method of carbohydrate counting has provided a significant improvement in glycemic control of patients.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Segundo a American Diabetes Association, é importante a ênfase no controle glicêmico com o objetivo de prevenir complicações microvasculares em diabéticos, e a adoção de um plano alimentar saudável é fundamental no tratamento destes pacientes. O método de contagem de carboidratos é uma estratégia nutricional, é um método usado por indivíduos diabéticos, que associa o total de carboidratos ingerido nas refeições com a dose de insulina utilizada, com o objetivo de manter a glicemia dentro dos limites convenientes. O objetivo desse estudo foi avaliar se a intervenção nutricional, utilizando o método de contagem de carboidratos, influencia o controle glicêmico de pacientes com diabetes mellitus tipo 1 (DM1). Foram avaliados 157 DM1, 96 constituíram o grupo intervenção com dieta prescrita e com o uso do método de contagem de carboidratos e 61 pacientes DM1 constituíram o grupo controle com dieta prescrita e sem contagem de carboidratos. Os diabéticos foram monitorados por um período de seis meses. Na primeira visita foram submetidos a um questionário de caracterização dos indivíduos, avaliação antropométrica, bioquímica, clínica e dietética. Houve diferença significativa entre o registro alimentar preenchido durante 3 dias e a dieta prescrita, nos gramas de proteína consumidos por dia 50,39 + 29,27 e 22,01 + 3,05 (p= 0,02), como também no índice glicêmico (IG) do almoço 43,00 + 24,89 e 7,83 + 1,88 (p=0,02), e do jantar 50,09 + 35,09 e 7,56 + 2,57 (p=0,00). Em relação a avaliação antropométrica houve aumento não significativo em ambos os grupos, no Índice de Massa Corporal calculado e nos parâmetros antropométricos (circunferência abdominal, circunferência de quadril e relação cintura-quadril). Na avaliação dos parâmetros bioquímicos, observa-se diminuição significativa, somente no grupo intervenção, da hemoglobina glicada (A1C) de 9,8 + 2,26 para 9,1 + 2,16 (p= 0,023) após 6 meses. As correlações entre os dados antropométricos e a A1C, e entre os diferentes tipos de ácidos graxos da dieta proposta e parâmetros bioquímicos colesterol, triglicerídeos, HDLc e LDLc plasmáticos foram consideradas de baixa intensidade. Diante dos resultados concluiu-se que a intervenção por meio do método de contagem de carboidratos proporcionou uma melhora significativa no controle glicêmico dos pacientes estudados. / According to the American Diabetes Association, is important to focus on glycemic control in order to prevent microvascular complications in patients with type 1 diabetes, and the adoption of a plan healthy food is crucial in treating these patients. The method of carbohydrate counting is a nutritional strategy, it is a method used by diabetic individuals, which combines the total carbohydrate intake at meals with the dose of insulin used, with the goal of maintaining blood glucose within the limits appropriate. The aim of this study was to assess whether the nutrition intervention, using the method of carbohydrate couting, influences the glycemic control of patients with diabetes mellitus type 1 (DM1). We evaluated 157 DM1, 96 constituted the intervention group with diet and the use of the method of carbohydrate counting and 61 DM1 patients formed the control group with diet and without the method of carbohydrate counting. The patients were monitored for six months. In the first visit were submitted to a questionnaire, anthropometric, biochemical, clinical and dietary evaluations. Significant difference between the food record completed for 3 days and prescribed diet, in grams of protein consumed per day 50.39 + 29.27 and 22.01 + 3.05 (p = 0.02), on the glycemic index (GI) of lunch 43.00 + 24.89 and 7.83 + 1.88 (p = 0.02), and dinner 50.09 + 35.09 and 7.56 + 2.57 (p = 0.00). For anthropometric assessment increase was not significant in both groups, the body mass index and anthropometric parameters (waist circumference, hip circumference and the waist-hip ratio). In the assessment of biochemical parameters, there is a significant decrease, only in the intervention group, the glycated hemoglobin (A1C) from 9.8 + 2.26 to 9,1 + 2.16 (p = 0.023) after 6 months. The correlations between the anthropometric data and A1C, and between different types of fatty acids in the diet proposal and biochemical parameters cholesterol, triglycerides, HDLc and LDLc plasma were of low intensity. The results concluded that intervention by the method of carbohydrate counting has provided a significant improvement in glycemic control of patients.

Background: The One Drop vertical bar Mobile app supports manual and passive (via HealthKit and One Drop's glucose meter) tracking of self-care and glycated hemoglobin A(1c) (HbA(1c)). Objective: We assessed the HbA(1c) change of a sample of people with type 1 diabetes (T1D) or type 2 diabetes (T2D) using the One Drop vertical bar Mobile app on iPhone and Apple Watch, and tested relationships between self-care tracking with the app and HbA(1c) change. Methods: In June 2017, we identified people with diabetes using the One Drop vertical bar Mobile app on iPhone and Apple Watch who entered two HbA(1c) measurements in the app 60 to 365 days apart. We assessed the relationship between using the app and HbA(1c) change. Results: Users had T1D (n=65) or T2D (n=191), were 22.7% (58/219) female, with diabetes for a mean 8.34 (SD 8.79) years, and tracked a mean 2176.35 (SD 3430.23) self-care activities between HbA(1c) entries. There was a significant 1.36% or 14.9 mmol/mol HbA(1c) reduction (F=62.60, P<.001) from the first (8.72%, 71.8 mmol/mol) to second HbA(1c) (7.36%, 56.9 mmol/mol) measurement. Tracking carbohydrates was independently associated with greater HbA(1c) improvement (all P<.01). Conclusions: Using One Drop vertical bar Mobile on iPhone and Apple Watch may favorably impact glycemic control.

Les hémorphines représentent une classe de peptides cryptiques bioactifs issus de la protéolyse de la chaîne ß de l’hémoglobine dont la présence in vivo a souvent été associée à des conditions physiologiques ou pathologiques particulières, comme les cancers. De ce fait, l’hypothèse d’utiliser ces peptides comme marqueur de pathologies avaient déjà été posé. Des études récentes au laboratoire ont montré que leur concentration sérique des hémorphines était diminuée chez les patients diabétiques. Nous avons travaillé sur une cohorte de 120 patients atteints de diabète de type 1 et 2 et nous avons étudié les différentes hypothèses permettant d’expliquer cette diminution : métabolisme des hémorphines, impact de la glycation de l’hémoglobine sur la libération des peptides. De plus, nous avons cherché à connaître le rôle de LVVH7 dans la signalisation insulinique. Les résultats obtenus suggèrent que la diminution de la concentration sérique des hémorphines de type 7 est spécifique du diabète mais que la glycation de l’hémoglobine n’a pas d’impact sur la libération des hémorphines. Parallèlement à cette étude, nous avons caractérisé les hémorphines de type 7 dans le microenvironnement du cancer broncho-pulmonaire. La cathepsine D, enzyme impliquée dans la libération de LVVH7 et VVH7 ainsi que dans le microenvironnement tumoral, a été étudié dans des cultures de lignées de cancers broncho-pulmonaires acidifiée et donc propice à la progression tumorale. Les résultats ont permis de confirmer la présence de la cathepsine D dans le surnageant de cultures des cellules cancéreuses. De plus, nous avons montré la libération d’hémorphines de type 7 dans des milieux de culture acidifiés. / Hemorphins are cryptic bioactive peptides derived from ß chain of haemoglobin proteolysis. Their biological presence has often been associated with physiological or pathological conditions, like cancers. Thus, it was already suggested that hemorphins could be used as marker of pathology. Previous studies achieved in our laboratory demonstrated that hemorphin-7 was decreased in serum of diabetic patients. We worked on a population of 120 patients with type 1 and type 2 diabetes and we studied different hypothesis: hemorphins metabolism, impact of glycated haemoglobin. Moreover, we researched the role of LVVH7 in insulin signalisation. The results suggested that hemorphin-7 concentrations in serum of diabetic patients are specific of this pathology but glycation of haemoglobin have no impact on liberation of hemorphins. In parallel, we characterized hemorphin-7 in tumor progression of lung cancers. Cathepsin D, previously demonstrated as a key enzyme in hemorphins generation and also in tumor progression, has been studied in vitro in lung cancers, cultured in acidified conditions, favourable to metastasis. In addition, we also identified hemorphin-7 liberation in acidified media culture.

Diabetes mellitus is one of the most common diseases worldwide. The continued prevalence increase, together with the complexity of the disease with severe long-term complications makes efficient diagnostical and monitorial methods very important. The determination of glycated hemoglobin, HbA1c, plays an important role in both, underlying the importance of high-quality analytical instruments. Whenever a new instrument is introduced into routine clinical use an evaluation is needed. This study evaluated the agreement between the new Tosoh G11 HbA1c high performance liquid chromatography system as a replacement for the Bio-Rad D-100 at the Chromatographic Department of the Institute of Laboratory Medicine, Faculty of Medicine, University of Debrecen. In total, 66 samples were analyzed using both analyzers and a Bland-Altman comparison was performed together with a correlation study. Additionally, a linearity check, optimal error and routine error testing was carried out specifically for the Tosoh G11. The results showed high agreement between measurements, r=0.9975 (p&lt;0.001) for HbA1c mmol/mol and r=0.9971 (p&lt;0.001) for HbA1c %. High repeatability and accuracy were observed of the Tosoh G11 with the highest variation coefficient of 1.50 % and linearity r =0.9999. The conducted study supports the replacement of the Bio-Rad D-100 to the Tosoh G11. / Diabetes mellitus är en av de vanligaste världsomfattande sjukdomarna. Fortsatt prevalensökning, tillsammans med den komplexa sjukdomsbilden innefattande allvarliga långsiktiga komplikationer gör effektiva diagnostiska och övervakande metoder väldigt viktiga. Bestämning av glykerat hemoglobin, HbA1c, spelar en viktig roll i båda, vilket kräver att analysinstrument av hög kvalitet finns. När ett nytt instrument introduceras inom kliniska rutinanalyser krävs utvärdering. Denna studie utvärderade överrensstämmelsen mellan det nya Tosoh G11 HbA1c högupplösande vätskekromatografisystemet som en ersättning för Bio-Rad D-100 på den kromatografiska enheten av laboratoriemedicin på Debrecens universitet. Totalt analyserades 66 prov med respektive instrument och Bland-Altman jämförelse genomfördes tillsammans med en korrelationsstudie. Dessutom utfördes ett linjäritetstest, optimal- och rutinfeltest specifikt för Tosoh G11. Resultaten visade en hög överrensstämmelse mellan mätningarna, r=9975 (p&lt;0.001) för HbA1c mmol/mol och r =9971 (p&lt;0.001) för HbA1c %. Tosoh G11 visade hög repeterbarhet och noggrannhet, med den högsta variationskoefficient på endast 1.50 % och en linjäritet på r=0.9999. Den genomförda studien stödjer Tosoh G11 som ersättning för Bio-Rad D-100.

Bakgrund: Diabetesbörda innefattar emotionella aspekter kopplade till diabetes och är korrelerat till sämre glykemisk kontroll samt suboptimal sjukdomshantering. Diabetesbörda är ett lågt prioriterat problem i diabetesvården och det föreligger ett stort mörkertal, därtill berörs diabetesbörda sparsamt i de svenska nationella riktlinjerna för diabetesvård. Syfte: Syftet var att undersöka samband mellan diabetesbörda och glykemisk kontroll, diabetesduration samt demografisk data hos personer med Diabetes mellitus typ 1.  Metod: Kvantitativ deskriptiv tvärsnittsstudie. Totalt inkluderades 69 personer. Examensarbetet utfördes på två diabetesmottagningar i Sverige. Studiedeltagarna besvarade enkäten Swe-PAID-20 samt frågor avseende kön, ålder och diabetesduration och aktuellt HbA1c registrerades. Data analyserades med icke-parametriska metoder. Resultat: Förhöjd diabetesbörda upplevdes av 20% av studiedeltagarna och 45% rapporterade något diabetesrelaterat problem som ganska allvarligt respektive mycket allvarligt. Högt HbA1c var korrelerat med behandlingsrelaterade problem samt stödrelaterade problem. Samband mellan diabetesbörda och övriga variabler samt skillnader mellan subgrupper påvisades inte.  Slutsats: Diabetesbörda är ett relativt vanligt förekommande problem i den undersökta populationen. Högt HbA1c påvisades vara en prediktor för behandling- och stödrelaterade problem. Ökad kunskap om diabetesbörda kan bidra till ökad personcentrering i diabetesvården, minskat lidande för den enskilde individen samt en resursbesparing för samhället genom att minska risken för komplikationer. Screening av diabetesbörda hos samtliga individer med T1D kan vara av värde, då diabetesbörda inte är mer vanligt förekommande i någon specifik grupp av personer. / Background: Diabetes distress includes emotional aspects linked to diabetes and correlates to poor glycemic control and suboptimal self-management. There is many unreported cases and diabetes distress is currently a low priority problem and is sparsely addressed in the Swedish national guidelines for diabetes care. Aim: The aim was to investigate the correlation between diabetes distress and glycemic control, duration of diabetes, and demographic data in people with Diabetes mellitus type 1. Method: A quantitative descriptive cross-sectional study. A total of 69 people were included. Data was collected from two diabetes clinics in Sweden. The participants answered the Swe-PAID-20 questionnaire and questions regarding gender, age, and diabetes duration and current HbA1c was noted. Data were analyzed using non-parametric methods. Main results: Increased diabetes distress was experienced by 20% of the participants and 45% reported a diabetes-related problem as a “somewhat serious problem” or a “serious problem”. Higher HbA1c correlated with treatment-related problems as well as support-related problems. Associations between diabetes distress and other variables and differences between subgroups were not detected. Conclusion: Diabetes distress was a relatively common problem in the studied population. Elevated HbA1c values indicated treatment and support related problems. Increased knowledge about diabetes distress can contribute to a more person-centered diabetes care, reduce suffering for the individual and save resources for society by reducing the risk of complications. Screening is important as diabetes distress is not more common in any specific population and helps to identify people in need of support.

The main objective of this study was research on biomarkers used in both diagnosis and therapy of diabetic complications. The main focus of our work came to be on one of these biomarkers - glycemic variability (GV). High GV is linked with more frequent occurance of hypoglycemia. There are even indications it might contribute to development of diabetic complications. With modern technology - continuous glucose monitoring (CGM), we are now able to reliably describe, calculate and reduce GV. So far it is unclear whether increased GV can contribute to the development of microvascular complications (MVC) in type 1 diabetes (T1D). Studies published so far have assessed GV primarily from routine self-monitoring of blood glucose (SMBG) using glucometers. In the light of this uncertaity, the first part of this work compares GV calculated from CGM with the presence of MVC in T1D patients. GV calculated from CGM, but not from SMBG, proved to be significantly higher in T1D patients with MVC, even though there was no significant difference in glycated hemoglobin (HbA1c). This finding supports the hypothesis that higher GV is related to higher risk of MVC and that HbA1c does not describe diabetes control completely. Moreover, it was shown that GV calculated from SMBG is insufficient. There is still no fully...